Pharmacokinetics of Creatinine in Man and Its Implications in the Monitoring of Renal Function and in Dosage Regimen Modifications in Patients with Renal Insufficiency

肾功能 养生 药代动力学 医学 肌酐 泌尿科 重症监护医学 药理学 内科学
作者
Win L. Chiou,FUNG H. HSU
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:15 (5-6): 427-434 被引量:82
标识
DOI:10.1002/j.1552-4604.1975.tb02364.x
摘要

A single-compartment model is proposed to describe the pharmacokinetics of creatinine in man. Based on the information from the literature, it was estimated that the average biological half-life of creatinine in normal male adults between 20 to 39 years old is 3.85 hours. This half-life is prolonged in renal patients and becomes 77 hours when renal function decreases to 5 per cent of normal. Based on pharmacokinetic analysis, it was also shown that the time required to reach a new steady-state serum creatinine level after onset of renal failure is highly dependent upon the degree of renal insufficiency. For example, for the subjects analyzed in this paper, it was estimated that it will take 1.1, 2.5, 6.7, and 13.4 days to reach 95 per cent of the steady-state levels when the renal function drops to 50, 25, 10, and 5 per cent of the normal capacity. The model analysis also predicts that from a practical point of view the daily fluctuation in serum level in patients with better than 25 per cent of normal renal function is not very significant. On the other hand, the fluctuation in the early stage of severe renal failure is predicted to be very dramatic. The analysis also predicts that the serum level will decrease to a normal or near normal value within two days after improvement of renal function from moderately to severely impaired state. The data obtained from an anuric patient seems to support the validity of the pharmacokinetic approach used in this study. The implications of the above pharmacokinetic analyses for the monitoring of renal function and dosage regimen modifications in patients with renal insufficiency were discussed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丸丸发布了新的文献求助10
1秒前
2秒前
Ayao完成签到,获得积分10
3秒前
slx0410完成签到,获得积分10
3秒前
小紫完成签到,获得积分10
3秒前
4秒前
今后应助小小橙采纳,获得10
4秒前
SciGPT应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得10
4秒前
Owen应助科研通管家采纳,获得10
4秒前
SYLH应助科研通管家采纳,获得30
4秒前
在水一方应助马马采纳,获得10
4秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
烟花应助末末采纳,获得10
5秒前
领导范儿应助科研通管家采纳,获得10
5秒前
5秒前
SYLH应助科研通管家采纳,获得30
5秒前
小二郎应助科研通管家采纳,获得10
5秒前
CodeCraft应助科研通管家采纳,获得10
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
静静应助科研通管家采纳,获得10
5秒前
5秒前
orixero应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
6秒前
刘光正发布了新的文献求助10
7秒前
无奈的醉薇完成签到,获得积分10
7秒前
wish完成签到,获得积分10
9秒前
王加通完成签到,获得积分10
9秒前
10秒前
111发布了新的文献求助10
10秒前
宇宙凛发布了新的文献求助10
10秒前
燃尔完成签到 ,获得积分10
11秒前
打打应助哈哈哈采纳,获得10
11秒前
大白发布了新的文献求助10
11秒前
星期八发布了新的文献求助10
12秒前
yuyan发布了新的文献求助10
13秒前
14秒前
yalan发布了新的文献求助10
15秒前
隐形曼青应助澡雪采纳,获得10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975816
求助须知:如何正确求助?哪些是违规求助? 3520159
关于积分的说明 11201128
捐赠科研通 3256541
什么是DOI,文献DOI怎么找? 1798347
邀请新用户注册赠送积分活动 877539
科研通“疑难数据库(出版商)”最低求助积分说明 806426